Local CMRGlc values were determined for 13 regions in each hemisphere from tomographs of patients with Alzheimer's, Huntington's, and Parkinson's diseases who were studied using [18F]fluorodeoxyglucose with positron emission computed tomography. Intercorrelations among the 26 regional measures were calculated for each disease state and for normal controls, and were accepted as reliable at p < 0.01, uncorrected for the number of comparisons. The number of reliable correlations was found to be decreased in Parkinson's and Huntington's diseases, two primarily subcortical disorders, and increased in Alzheimer's disease, a primarily cortical disorder. The changes suggest that one role of the basal ganglia involves coordinating or pacing the ability of cortical brain regions to function as a unit.
BensonD.F.KuhlD.E.HawkinsR.A.PhelpsM.E.CummingsJ.L.TsaiS.Y. (1983) The fluorodeoxyglucose 18F scan in Alzheimer and multiinfarct dementia. Arch Neurol40:711–714.
2.
BesA.GuellA.FabreN.DupuiP.H.VictorG.GeraudG. (1983) Cerebral blood flow studied by xenon-133 inhalation technique in parkinsonism: Loss of hyperfrontal pattern. J Cereb Blood Flow Metabol3:33–37.
3.
DeLeonM.J.GeorgeA.E.FerrisS.H.RosenbloomS.ChristmanD.R.GentesC.I.ReisbergB.KricheffIIWolfA.P. (1983a) Regional correlation of PET and CT in senile dementia of the Alzheimer type. AJNR5:553–556.
4.
DeLeonM.J.FerrisS.H.GeargeA.E.ChristmanD.R.FowlerJ.S.GentesC.ReisbergB.GeeB.EmmerichM.YoshiharuY.BrodieJ.KricheffIIWolfA.P. (1983b) Positron emission tomographic studies of aging and Alzheimer disease. AJNR4:568–571.
5.
DivacI.ObergR.G.E. (1979) Current conceptions of neostriatal functions, history and an evaluation. In: The Neostriatum (DivacI.ObergR.G.E., eds), Oxford, Pergamon Press, pp 215–230.
6.
FabreN.AdamP.GeraudG.GuellA.RoulleauJ.BesA. (1983) Correlations between CBF and CT scan in parkinsonism. J Cerebr Blood Flow Metabol3 (suppl 1):S516–S517.
7.
FarkasT.FerrisS.H.WolfA.P.DeLeonM.J.ChristmasD.R.ReisbergB.AlaviA.FowlerJ.S.GeorgeA.E.ReivichM. (1982) 18F-2-Deoxy-2-fluoro-d-glucose as a tracer in the positron emission tomographic study of senile dementia. Am J Psychiatry139:352–353.
8.
FrackowiakR.S.J.PozzilliC.LeggN.J.DuBoulayG.H.MarshallJ.LenziG.L.JonesT. (1981) Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain104:753–778.
9.
FriedlandR.P.BudingerT.F.YanoY.HuesmanR.H.KnittelB.DerenzoS.E.KossB.OberB.A. (1983) Regional cerebral metabolic alterations in Alzheimer-type dementia: Kinetic studies with 18-fluorodeoxyglucose. J Cereb Blood Flow Metabol3(suppl 1):S510–S511.
10.
GlobusM.MildorfB.MelamedE. (1983) rCBF changes in Parkinson's disease: Correlation with dementia. J Cereb Blood Flow Metabol3(suppl 1):S508–S509.
11.
HawkinsR.A.MazziottaJ.C.PhelpsM.E.HuangS.C.KuhlD.E.CarsonR.E.MetterE.J.RiegeW.H. (1983) Cerebral glucose metabolism as a function of age in man: The influence of the rate constants in the FDG method. J Cereb Blood Flow Metabol3:250–253.
12.
HaysW.L. (1973) Statistics for the Social Sciences. 2nd ed.New York, Holt, Rinehart & Winston.
13.
HerscovitchP.MinturnM.A.GordoM.RaichleM.E. (1983) The necessity for correcting for cerebral atrophy in global positron emission tomography measurements. J Nucl Med24:P106.
14.
HuangS.C.PhelpsM.E.HoffmanE.J.SiderisK.SelinC.J.KuhlD.E. (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol238:E69–E82.
15.
KempJ.M.PowellT.P.S. (1970) The cortico-striate projection in the monkey. Brain93:526–546.
16.
KuhlD.E.PhelpsM.E.MarkhamC.H.MetterE.J.RiegeW.H.WinterJ. (1982) Cerebral metabolism and atrophy in Huntington's disease determined by FDG and CT scan. Ann Neurol12:425–434.
17.
KuhlD.E.MetterE.J.RiegeW.H.HawkinsR.A.MazziottaJ.C.PhelpsM.E.KlingA.S. (1983) Local cerebral glucose utilization in elderly patients with depression, multiple infarct dementia, and Alzheimer's disease. J Cereb Blood Flow Metabol3(suppl 1):S494–S495.
18.
KuhlD.E.MetterE.J.RiegeW.H. (1984) Patterns of local cerebral glucose utilization determined in Parkinson's disease by the (18F) fluorodeoxyglucose method. Ann Neurol15:419–424.
19.
LavyS.MelamedE.CooperG.BentinS.RinotY. (1979) Regional cerebral blood flow in patients with Parkinson's disease. Arch Neurol36:344–348.
20.
LeendersK.WolfsonL.GibbsJ.WiseR.JonesT.LeggN. (1983) Regional cerebral blood flow and oxygen metabolism in Parkinson's disease and their response to l-DOPA. J Cereb Blood Flow Metabol3(suppl 1):S488–S489.
21.
LenziG.L.JonesT.ReidJ.L.MossS. (1979) Regional impairment of cerebral oxidative metabolism in Parkinson's disease. J Neurol Neurosurg Psychiatry42:59–62.
22.
MatsuiT.HiranoA. (1978) An Atlas of the Human Brain for Computerized Tomography. Tokyo, Igaku-Shoin.
23.
MazziottaJ.C.PhelpsM.E.CarsonR.E.KuhlD.E. (1982) Tomographic mapping of human cerebral metabolism: Auditory stimulation. Neurology32:921–937.
24.
MetterE.J.RiegeW.H.KuhlD.E.PhelpsM.E. (1983) Differences in regional glucose metabolic intercorrelations with aging. J Cereb Blood Flow Metabol3(suppl 1):S482–S483.
25.
MetterE.J.RiegeW.H.KuhlD.E.PhelpsM. (1984) Cerebral metabolic relationships for selected brain regions in healthy adults. J Cereb Blood Flow Metabol4:1–7.
26.
PhelpsM.E.HoffmanE.J.HuangS.C.KuhlD.E. (1978) ECAT: A new computerized tomographic imaging system for positron emitting radiopharmaceuticals. J Nucl Med19:635–647.
27.
PhelpsM.E.HuangS.C.HoffmanE.J.SelinC.S.SokoloffL.KuhlD.E. (1979) Tomographic measurement of local cerebral metabolic rate in humans with (F-18) 2-fluoro-2-deoxyglucose: Validation of method. Ann Neurol6:371–388.
28.
PhelpsM.E.MazziottaJ.C.KuhlD.E.NuwerM.PackwoodJ.MetterJ.EngelJ.Jr (1981) Tomographic mapping of human cerebral metabolism: Visual stimulation and deprivation. Neurology31:517–529.
29.
RougemontD.BaronJ-CCollartP.BustanyP.ComarD.AgidY. (1983) Local cerebral metabolic rate of glucose (LCMRglc) in treated and untreated patients with Parkinson's disease. J Cereb Blood Flow Metabol3(suppl 1):S504–S505.
30.
YeterianE.H.Van HoesenG.W. (1978) Cortico-striate projections in the rhesus monkey: The organization of certain cortico-caudate connections. Brain Res139:43–63.
